TGTX Cost Of Revenue from 2010 to 2024

TGTX Stock  USD 32.16  0.04  0.12%   
TG Therapeutics Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue is likely to outpace its year average in 2024. During the period from 2010 to 2024, TG Therapeutics Cost Of Revenue regression line of annual values had r-squared of  0.01 and arithmetic mean of  25,041,251. View All Fundamentals
 
Cost Of Revenue  
First Reported
1998-12-31
Previous Quarter
8.4 M
Current Value
9.3 M
Quarterly Volatility
8.1 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TG Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TG Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 444.1 K, Interest Expense of 13.2 M or Total Revenue of 245.3 M, as well as many indicators such as Price To Sales Ratio of 9.86, Dividend Yield of 4.0E-4 or PTB Ratio of 15.86. TGTX financial statements analysis is a perfect complement when working with TG Therapeutics Valuation or Volatility modules.
  
Check out the analysis of TG Therapeutics Correlation against competitors.
For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.

Latest TG Therapeutics' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of TG Therapeutics over the last few years. Cost of Revenue is found on TG Therapeutics income statement and represents the costs associated with goods and services TG Therapeutics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is TG Therapeutics' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TG Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Very volatile
   Cost Of Revenue   
       Timeline  

TGTX Cost Of Revenue Regression Statistics

Arithmetic Mean25,041,251
Geometric Mean0.00
Coefficient Of Variation147.86
Mean Deviation28,914,666
Median790,000
Standard Deviation37,027,098
Sample Variance1371T
Range118.9M
R-Value(0.09)
Mean Square Error1464.8T
R-Squared0.01
Significance0.75
Slope(736,252)
Total Sum of Squares19194.1T

TGTX Cost Of Revenue History

202422 M
202314.6 M
2022265 K
2021790 K
2020374 K
2019282 K
201888 K

About TG Therapeutics Financial Statements

TG Therapeutics investors use historical fundamental indicators, such as TG Therapeutics' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TG Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue14.6 M22 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TGTX Stock Analysis

When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.